COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead Our Letter to Patients
Ironman Athlete Takes On Primary Immunodeficiency
The race has changed, but marathoner Stacy Ahearn is still pushing ahead following a rare disease diagnosis at age 40.
Listen: Why We Do Clinical Trials
Podcast explores why clinical trials are so essential to advancements for patients.
Two Grants Awarded In Transplant Medicine
Work in this transformative area of medicine continues amid the COVID-19 pandemic.
Take the UNICEF Quiz About COVID-19
Global children’s charity, physicians and scientists aim to “spread facts” and fight misinformation.
How to put your best (virtual) foot forward.
With more job interviews happening online because of COVID-19, CSL Behring’s Talent Acquisition team shares best practices fo…
The Fight Is In Us
With a mission to encourage plasma donations, a new campaign finds support from a COVID-19 survivor group, medical research c…
Dr. David Fajgenbaum Takes on COVID-19
University of Pennsylvania research team examines the “cytokine storm” in pursuit of effective treatments.
New Leader Takes Over at BIO
During a pandemic, the global biotech organization hires Dr. Michelle McMurry-Heath to tell the story of science.
Family Adopts a Son Who Has Hemophilia
Meet the Smith Family
A U.S. family opens their home, and hearts, to a new son who has hemophilia.